Comparison of effects of different, long-term iron chelation regimens on myocardialand hepatic iron concentrations assessed with T2*MRI in patients with β-thalassaemia major

被引:0
|
作者
Perifanis, V.
Christoforidis, A.
Vlachaki, E.
Tsatra, I.
Spanos, G.
Athanassiou-Metaxa, M.
机构
[1] Ippokrat Hosp, Thessaloniki, Greece
[2] Diagnost Lab Eurodiag, Thessaloniki, Greece
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0803
引用
收藏
页码:300 / 301
页数:2
相关论文
共 50 条
  • [21] Long-term effects of combined chelation therapy in thalassemia major patients with iron-induced cardiomyopathy
    Pepe, A.
    Grady, R.
    Vacquer, S.
    Carta, P.
    Sau, F.
    Bina, P.
    Cianciulli, P.
    Maggio, A.
    Lombardi, M.
    Lai, M. E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 51 - 51
  • [22] Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with β-thalassaemia major:: application of SQUID biomagnetic liver susceptometry
    Fischer, R
    Longo, F
    Nielsen, P
    Engelhardt, R
    Hider, RC
    Piga, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (06) : 938 - 948
  • [23] Iron overload in hemodialysis patients: Comparison of serum iron parameters with T2*MRI sequence
    Delibas, Deniz
    Evrimler, Sehnaz
    Ercan, Karabekir
    Gumus, Mehmet
    Sariyildirim, Abdullah
    Arslan, Halil
    JOURNAL OF CLINICAL ULTRASOUND, 2024, 52 (02) : 124 - 130
  • [24] MRI evaluation of hepatic and cardiac iron burden in pediatric thalassemia major patients: spectrum of findings by T2*
    Samar M. Shehata
    Mohamed I. Amin
    El Sayed H. Zidan
    Egyptian Journal of Radiology and Nuclear Medicine, 50
  • [25] MRI evaluation of hepatic and cardiac iron burden in pediatric thalassemia major patients: spectrum of findings by T2
    Shehata, Samar M.
    Amin, Mohamed, I
    Zidan, El Sayed H.
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2019, 50 (01):
  • [26] Is cardiac and hepatic iron status assessed by MRI T2*associated with left ventricular function in patients with idiopathic cardiomyopathy?
    Kanzaki, Yumiko
    Yuki, Masako
    Yamamura, Ken-ichiro
    Narumi, Yoshifumi
    Ishizaka, Nobukazu
    HEART AND VESSELS, 2016, 31 (12) : 1950 - 1959
  • [27] Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?
    Yumiko Kanzaki
    Masako Yuki
    Ken-ichiro Yamamura
    Yoshifumi Narumi
    Nobukazu Ishizaka
    Heart and Vessels, 2016, 31 : 1950 - 1959
  • [28] Cardiac iron overload in patients with beta thalassaemia major: continued improvement and normalization of myocardial T2*with up to 3 years deferasirox (Exjade) oral iron chelation treatment
    Pennell, D. J.
    EUROPEAN HEART JOURNAL, 2011, 32 : 986 - 986
  • [29] Long-term evaluation of the efficiency of iron chelation in thalassemia major with balance studies using hepatic iron concentration to determine body iron stores.
    Brittenham, GM
    Taylor, CM
    Angelucci, E
    Olivieri, NF
    BLOOD, 1998, 92 (10) : 38B - 38B
  • [30] COMPARISON OF IRON CHELATION EFFECTS OF DEFEROXAMINE, DEFERASIROX, AND COMBINATION OF DEFEROXAMINE AND DEFERIPRONE ON LIVER AND CARDIAC T2*MRI IN THALASSEMIA MAIOR
    Ansari, S.
    Abadi, G. Miri Ali
    Azarkeivan, A.
    HAEMATOLOGICA, 2015, 100 : 595 - 595